Dyspnea · COPD
1 finding from 1 review
Serum or plasma zinc (in µmol/L) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Stunting · general population of all age groups (including pregnant women) from any country, over two years of age
Foods fortified with zinc alone showed no clear difference in stunting (author defined) compared with same foods without adding zinc (low certainty).
1 finding from 1 review
Underweight · general population of all age groups (including pregnant women) from any country, over two years of age
Foods fortified with zinc alone showed no clear difference in underweight (author defined) compared with same foods without adding zinc (low certainty).
1 finding from 1 review
Zinc deficiency (as defined by authors, depending on age and gender) · general population of all age groups (including pregnant women) from any country, over two years of age
It is very uncertain whether foods fortified with zinc plus other micronutrients changes zinc deficiency (as defined by authors, depending on age and gender) compared with foods fortified with other micronutrients without zinc (very low certainty).
1 finding from 1 review
Serum or plasma zinc (in µmol/L) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Intervention not reported
Change in Exercise Capacity (6MWD) · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
1 finding from 1 review
Intervention not reported
Mortality · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
The intervention showed no clear difference in mortality (low certainty).
1 finding from 1 review
Intervention not reported
Improvement in WHO Functional Class · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
The intervention showed no clear difference in improvement in WHO Functional Class (low certainty).
1 finding from 1 review
Intervention not reported
Serious Adverse Events (Participants with one or more event) · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
It is very uncertain whether the intervention changes serious Adverse Events (Participants with one or more event) (very low certainty).
1 finding from 1 review
Overall mortality · preterm infants with severe pulmonary dysfunction
Rescue high‐frequency jet ventilation showed no clear difference in overall mortality compared with conventional ventilation (low certainty).
1 finding from 1 review
Mortality before cross‐over · preterm infants with severe pulmonary dysfunction
Rescue high‐frequency jet ventilation probably leads to lower mortality before cross‐over compared with conventional ventilation (moderate certainty).
1 finding from 1 review
Chronic lung disease · preterm infants with severe pulmonary dysfunction
Rescue high‐frequency jet ventilation showed no clear difference in chronic lung disease at 28 days of birth (CLD 28 days) compared with conventional ventilation (low certainty).
2 findings from 1 review
Severe intraventricular haemorrhage · preterm infants with severe pulmonary dysfunction
Rescue high‐frequency jet ventilation showed no clear difference in severe intraventricular haemorrhage (grades 3 and 4) compared with conventional ventilation (low certainty).
1 finding from 1 review
Neurodevelopmental outcomes · preterm infants with severe pulmonary dysfunction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dyspnoea ‐ CRQ dyspnoea Scale 1 to 7. Higher is better and 0.5 units is a clinically important difference · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in SGRQ total score · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in incremental shuttle walk distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change from baseline in 6MWT (metres) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Exercise capacity · patients with chronic obstructive pulmonary disease
1 finding from 1 review